{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:49:10Z","timestamp":1790606950101,"version":"4.1.0"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,5]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>This study aims to determine the bibliometric characteristics of scientific articles on intra-arterial chemotherapy for retinoblastoma worldwide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The Web of Science database was used to conduct a comprehensive search strategy, which included all languages, countries or regions, affiliations, journals, research areas. The search ultimately yielded 256 articles that met the predefined inclusion criteria and were manually reviewed. The study employed a bibliometric analysis using quantitative bibliometric indicators and network analysis with co-authorship and co-occurrence of terms, using the bibliometrix package in R and VOSviewer, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The number of publications has been increasing since the first publication in 2010, with the largest number in 2021 (36 articles). The average number of citations per document was 13.32, and the annual growth rate was 5.38%. The most prolific country and authors were from the United States. Carol Lally Shields had the most contributions (53 articles), and the most cited study was published by Gobin et al in 2011. The journal with the most publications was JAMA Ophthalmology. The most commonly used keywords were Retina, Enucleation, and Periocular around 2016, while Radiation, Advanced age, and External carotid artery were commonly used around 2020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The United States is the most prolific country in this topic, with a large publication output but a low collaboration among other countries. Low- and middle-income countries should also be encouraged to implement research to contribute to the advancement of knowledge on intra-arterial chemotherapy for retinoblastoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049223","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:01:44Z","timestamp":1780718504000},"page":"e49223","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Global research trends on intra-arterial chemotherapy for retinoblastoma: A bibliometric and visualized study"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8056-2112","authenticated-orcid":false,"given":"Fabriccio J.","family":"Visconti-Lopez","sequence":"first","affiliation":[{"name":"Universidad Cient\u00edfica del Sur, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4622-7118","authenticated-orcid":false,"given":"Giancarlo","family":"Saal-Zapata","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery. Hospital Nacional Guillermo Almenara Irigoyen-EsSalud, La Victoria, Lima, Peru"},{"name":"Department of Interventional Neurosurgery, Clinica Angloamericana, San Isidro, Lima, Peru."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260711","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1136\/bjo.2008.150292","article-title":"The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death.","volume":"93","author":"Kivela","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"R2-20260711","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.4103\/ijo.IJO_721_20","article-title":"Modern treatment of retinoblastoma: a 2020 review.","volume":"68","author":"Ancona-Lezama","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"R3-20260711","first-page":"1","article-title":"Update on intra-arterial chemotherapy for retinoblastoma.","volume":"2014","author":"Zanaty","year":"2014","journal-title":"Sci World J"},{"key":"R4-20260711","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3171\/2012.5.PEDS1277","article-title":"Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma: a review.","volume":"10","author":"Jabbour","year":"2012","journal-title":"J Neurosurg Pediatr"},{"key":"R5-20260711","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archophthalmol.2011.5","article-title":"Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience.","volume":"129","author":"Gobin","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"R6-20260711","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.ophtha.2007.12.014","article-title":"A phase I\/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma.","volume":"115","author":"Abramson","year":"2008","journal-title":"Ophthalmology"},{"key":"R7-20260711","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.ophtha.2009.12.030","article-title":"Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).","volume":"117","author":"Abramson","year":"2010","journal-title":"Ophthalmology"},{"key":"R8-20260711","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000491580","article-title":"Primary intra-arterial chemotherapy for retinoblastoma in the intravitreal chemotherapy era: five years of experience.","volume":"5","author":"Dalvin","year":"2019","journal-title":"Ocul Oncol Pathol"},{"key":"R9-20260711","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4143\/crt.2021.1537","article-title":"The efficacy of alternate systemic intravenous chemotherapy and intra-arterial chemotherapy approach for eye globe salvage in retinoblastoma.","volume":"55","author":"Han","year":"2023","journal-title":"Cancer Res Treat"},{"key":"R10-20260711","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4103\/ijo.IJO_1388_22","article-title":"Intra-arterial chemotherapy in refractory and advanced intraocular retinoblastoma.","volume":"71","author":"Kumari","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"R11-20260711","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jfo.2015.03.004","article-title":"Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.","volume":"38","author":"Shields","year":"2015","journal-title":"J Fr Ophtalmol"},{"key":"R12-20260711","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1007\/s12094-021-02610-z","article-title":"The role for intra-arterial chemotherapy for refractory retinoblastoma: a systematic review.","volume":"23","author":"Runnels","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"R13-20260711","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1136\/neurintsurg-2019-014909","article-title":"Intra-arterial chemotherapy for retinoblastoma: an updated systematic review and meta-analysis.","volume":"11","author":"Ravindran","year":"2019","journal-title":"J Neurointerven Surg"},{"key":"R14-20260711","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/jamaophthalmol.2016.0244","article-title":"Intra-arterial chemotherapy for retinoblastoma: a systematic review.","volume":"134","author":"Yousef","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"R15-20260711","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jbusres.2019.11.025","article-title":"A bibliometric analysis of board diversity: current status, development, and future research directions.","volume":"108","author":"Kent Baker","year":"2020","journal-title":"J Bus Res"},{"key":"R16-20260711","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1016\/j.wneu.2021.06.029","article-title":"Predictors of citations in neurosurgical research: a 5-year follow-up.","volume":"153","author":"Lee","year":"2021","journal-title":"World Neurosurg"},{"key":"R17-20260711","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/j.wneu.2019.05.226","article-title":"Predictors of citations in neurosurgical research.","volume":"130","author":"Oravec","year":"2019","journal-title":"World Neurosurg"},{"key":"R18-20260711","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/08820538.2016.1154177","article-title":"Disparities in retinoblastoma presentation, treatment, and outcomes in developed and less-developed countries.","volume":"31","author":"Singh","year":"2016","journal-title":"Semin Ophthalmol"},{"key":"R19-20260711","doi-asserted-by":"crossref","first-page":"e380","DOI":"10.1016\/S2214-109X(21)00555-6","article-title":"Global retinoblastoma survival and globe preservation: a systematic review and meta-analysis of associations with socioeconomic and health-care factors.","volume":"10","author":"Wong","year":"2022","journal-title":"Lancet Global Health"},{"key":"R20-20260711","article-title":"Osteonecrosis research in orthopedics and traumatology: a global bibliometric analysis of publication trends, key contributors, and thematic evolution [published online ahead of print May 19, 2026].","author":"Pomasonco-Olivas","journal-title":"Orthop Surg"},{"key":"R21-20260711","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11701-026-03435-0","article-title":"The global landscape of robot-assisted pedicle screws: a bibliometric and thematic evolution analysis.","volume":"20","author":"Ma\u00f1uico Antay","year":"2026","journal-title":"J Robot Surg"},{"key":"R23-20260711","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joi.2017.08.007","article-title":"Bibliometrix : an R-tool for comprehensive science mapping analysis.","volume":"11","author":"Aria","year":"2017","journal-title":"J Inform"},{"key":"R24-20260711","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping.","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"R25-20260711","doi-asserted-by":"crossref","first-page":"e1128","DOI":"10.1016\/S2214-109X(22)00250-9","article-title":"The global retinoblastoma outcome study: a prospective, cluster-based analysis of 4064 patients from 149 countries.","volume":"10","year":"2022","journal-title":"Lancet Global Health"},{"key":"R26-20260711","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1200\/GO.20.00321","article-title":"Assessment of retinoblastoma capacity in the Middle East, North Africa, and West Asia Region.","volume":"6","author":"Burges","year":"2020","journal-title":"JCO Glob Oncol"},{"key":"R27-20260711","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1136\/bjo.2009.168062","article-title":"Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators.","volume":"94","author":"Canturk","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"R28-20260711","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1097\/MPH.0b013e31821d18f9","article-title":"Clinical presentation of retinoblastoma in a middle-income country.","volume":"34","author":"Navo","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"key":"R29-20260711","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/pbc.22843","article-title":"Strategies to manage retinoblastoma in developing countries.","volume":"56","author":"Chantada","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R30-20260711","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1442-9071.2010.02297.x","article-title":"Intra-arterial chemotherapy for retinoblastoma: the beginning of a long journey.","volume":"38","author":"Shields","year":"2010","journal-title":"Clin Exp Ophthalmol"},{"key":"R31-20260711","doi-asserted-by":"crossref","first-page":"105824","DOI":"10.1016\/j.clineuro.2020.105824","article-title":"Intra-arterial chemotherapy for retinoblastoma via the transradial route: technique, feasibility, and case series.","volume":"194","author":"Al Saiegh","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"key":"R32-20260711","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/neurintsurg-2019-015627","article-title":"Intra-arterial chemotherapy for retinoblastoma: transradial and transfemoral approach.","volume":"12","author":"Sweid","year":"2020","journal-title":"J Neurointerv Surg"},{"key":"R33-20260711","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/neuros\/nyaa142","article-title":"The use of alternative routes for the delivery of intra-arterial chemotherapy for retinoblastoma.","volume":"87","author":"Sweid","year":"2020","journal-title":"Neurosurgery"},{"key":"R34-20260711","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.wneu.2010.09.027","article-title":"Neurosurgeons involved in the treatment of retinoblastoma.","volume":"74","author":"Jabbour","year":"2010","journal-title":"World Neurosurg"},{"key":"R35-20260711","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/IIO.0000000000000266","article-title":"What\u2019s new in intra-arterial chemotherapy for retinoblastoma?","volume":"59","author":"Abramson","year":"2019","journal-title":"Int Ophthalmol Clin"},{"key":"R36-20260711","doi-asserted-by":"crossref","first-page":"822330","DOI":"10.3389\/fonc.2022.822330","article-title":"Treatment of retinoblastoma: what is the latest and what is the future.","volume":"12","author":"Schaiquevich","year":"2022","journal-title":"Front Oncol"},{"key":"R37-20260711","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/ICU.0b013e328338676a","article-title":"Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy.","volume":"21","author":"Shields","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"key":"R38-20260711","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.ophtha.2014.01.026","article-title":"Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.","volume":"121","author":"Shields","year":"2014","journal-title":"Ophthalmology"},{"key":"R39-20260711","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/13816810802464320","article-title":"The effect of therapy refusal against medical advice in retinoblastoma patients in a setting where treatment delays are common.","volume":"30","author":"Sitorus","year":"2009","journal-title":"Ophthalmic Genet"},{"key":"R40-20260711","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41433-018-0244-7","article-title":"Retinoblastoma in Asia.","volume":"33","author":"Jain","year":"2019","journal-title":"Eye (Lond)"},{"key":"R41-20260711","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajo.2021.09.026","article-title":"Contemporary update of retinoblastoma in China: three-decade changes in epidemiology, clinical features, treatments, and outcomes.","volume":"236","author":"Luo","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"R42-20260711","doi-asserted-by":"crossref","first-page":"e27086","DOI":"10.1002\/pbc.27086","article-title":"Feasibility and results of an intraarterial chemotherapy program for the conservative treatment of retinoblastoma in Argentina.","volume":"65","author":"Funes","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"R43-20260711","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1016\/j.wneu.2022.06.064","article-title":"Neurosurgery research productivity in Latin American and Caribbean countries: a bibliometric and visualized study.","volume":"165","author":"Visconti-Lopez","year":"2022","journal-title":"World Neurosurg"},{"key":"R44-20260711","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/107327481602300203","article-title":"Therapeutic options for retinoblastoma.","volume":"23","author":"Mendoza","year":"2016","journal-title":"Cancer Control"},{"key":"R45-20260711","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000438958","article-title":"Chemotherapy for Malignant Intraocular Tumors.","volume":"55","author":"Shah","year":"2016","journal-title":"Dev Ophthalmol"},{"key":"R46-20260711","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00247-020-04892-x","article-title":"Radiation dose reduction during intra-arterial chemotherapy for retinoblastoma: a retrospective analysis of 96 consecutive pediatric interventions using five distinct protocols.","volume":"51","author":"Monroe","year":"2021","journal-title":"Pediatr Radiol"},{"key":"R47-20260711","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/15910199221067664","article-title":"Investigation into the ophthalmic artery and its branches by superselective angiography.","volume":"28","author":"Akdemir Akta\u015f","year":"2022","journal-title":"Interv Neuroradiol"},{"key":"R48-20260711","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.3174\/ajnr.A3019","article-title":"Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: alternatives to direct ophthalmic artery catheterization.","volume":"33","author":"Klufas","year":"2012","journal-title":"AJNR Am J Neuroradiol"},{"key":"R49-20260711","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/09286586.2021.2013900","article-title":"The incidence of retinoblastoma in South Africa: findings from the South African National Cancer Registry (2004-2018).","volume":"29","author":"Stuart","year":"2022","journal-title":"Ophthalmic Epidemiol"},{"key":"R50-20260711","article-title":"Epidemiology and survival of childhood cancer in Turkey.","volume":"68","author":"Kebudi","year":"2020","journal-title":"Pediatric Blood Cancer"},{"key":"R51-20260711","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/19714009211024632","article-title":"Contralateral catheterization of the ophthalmic artery to deliver intra-arterial chemotherapy in retinoblastoma.","volume":"34","author":"Saal-Zapata","year":"2021","journal-title":"Neuroradiol J"},{"key":"R52-20260711","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1055\/s-0041-1727584","article-title":"Retrograde approach for intra-arterial chemotherapy delivery in retinoblastoma.","volume":"5","author":"Saal-Zapata","year":"2021","journal-title":"J Clin Interven Radiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049223","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:02:11Z","timestamp":1783778531000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":51,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049223","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"2025-02-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}